To better understand the potential benefit of brewing peptides on hypertension, their impact on ACE activity was compared with the effect elicited by captopril (at 1 μM dissolved in the same buffer as samples), a conventional anti-hypertensive drug that present ACE-inhibitory capacity. This evidence concerns the gene ACE and Hypertension.